Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.

This study has been completed.
Sponsor:
Information provided by:
Sosei
ClinicalTrials.gov Identifier:
NCT00141934
First received: August 31, 2005
Last updated: April 4, 2007
Last verified: April 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given